Latest News and Press Releases

Palo Alto, April 17, 2025 (GLOBE NEWSWIRE) -- Cancer patients don’t just fight the disease - they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to...

Ottawa, April 16, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global oncology market size surpassed USD 225.04 billion in 2024. The market size is expected to exceed USD 674.38 billion by...

CAMBRIDGE, United Kingdom and NEW YORK, April 15, 2025 – Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today...

Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan...

CRANBURY, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- CURE® Media Group and Oncology Nursing News® are pleased to announce that Kaifan Zhao, AGACNP-BC, PMHNP-BC, is the winner of the 2025 Extraordinary...

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors.

– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation...

CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with...

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference